Suppr超能文献

门诊环境中药物依从性测量的预测效度。

Predictive validity of a medication adherence measure in an outpatient setting.

作者信息

Morisky Donald E, Ang Alfonso, Krousel-Wood Marie, Ward Harry J

机构信息

Department of Community Health Sciences, UCLA School of Public Health, Los Angeles, CA 90095-1772, USA.

出版信息

J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x.

Abstract

This study examines the psychometric properties and tests the concurrent and predictive validity of a structured, self-reported medication adherence measure in patients with hypertension. The authors also assessed various psychosocial determinants of adherence, such as knowledge, social support, satisfaction with care, and complexity of the medical regimen. A total of 1367 patients participated in the study; mean age was 52.5 years, 40.8% were male, 76.5% were black, 50.8% graduated from high school, 26% were married, and 54.1% had income <$5,000. The 8-item medication adherence scale was reliable (alpha=.83) and significantly associated with blood pressure control (P<.05). Using a cutpoint of <6, the sensitivity of the measure to identify patients with poor blood pressure control was estimated to be 93%, and the specificity was 53%. The medication adherence measure proved to be reliable, with good concurrent and predictive validity in primarily low-income, minority patients with hypertension and might function as a screening tool in outpatient settings with other patient groups.

摘要

本研究考察了一种结构化的、自我报告的高血压患者药物依从性测量方法的心理测量特性,并测试了其同时效度和预测效度。作者还评估了依从性的各种心理社会决定因素,如知识、社会支持、对治疗的满意度以及医疗方案的复杂性。共有1367名患者参与了该研究;平均年龄为52.5岁,40.8%为男性,76.5%为黑人,50.8%高中毕业,26%已婚,54.1%收入低于5000美元。这个8项的药物依从性量表是可靠的(α = 0.83),并与血压控制显著相关(P < 0.05)。使用<6的切点,该测量方法识别血压控制不佳患者的敏感性估计为93%,特异性为53%。在主要为低收入的高血压少数族裔患者中,药物依从性测量方法被证明是可靠的,具有良好的同时效度和预测效度,并且在门诊环境中对其他患者群体可能起到筛查工具的作用。

相似文献

1
Predictive validity of a medication adherence measure in an outpatient setting.
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x.
2
Concurrent and predictive validity of a self-reported measure of medication adherence.
Med Care. 1986 Jan;24(1):67-74. doi: 10.1097/00005650-198601000-00007.
4
The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults.
Res Social Adm Pharm. 2014 May-Jun;10(3):554-61. doi: 10.1016/j.sapharm.2013.10.006. Epub 2013 Oct 26.
5
Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.
Int J Clin Pharm. 2011 Feb;33(1):132-40. doi: 10.1007/s11096-010-9474-x. Epub 2011 Jan 13.
6
Baseline medication adherence and blood pressure in a 24-month longitudinal hypertension study.
J Clin Nurs. 2012 May;21(9-10):1401-6. doi: 10.1111/j.1365-2702.2011.03859.x. Epub 2011 Nov 23.
7
Determinants of adherence to treatment in hypertensive patients of African descent and the role of culturally appropriate education.
PLoS One. 2015 Aug 12;10(8):e0133560. doi: 10.1371/journal.pone.0133560. eCollection 2015.
10
Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting.
J Clin Hypertens (Greenwich). 2007 Mar;9(3):179-86. doi: 10.1111/j.1524-6175.2007.06372.x.

引用本文的文献

2
Health Literacy and Medication Adherence in Polypharmacy: A Systematic Review for Clinical Practice.
Cureus. 2025 Jul 19;17(7):e88301. doi: 10.7759/cureus.88301. eCollection 2025 Jul.
4
Non-adherence to anti diabetic medication and associated factors in Nepal: a systematic review and meta-analysis.
Ann Med Surg (Lond). 2025 Jul 9;87(8):5185-5195. doi: 10.1097/MS9.0000000000003563. eCollection 2025 Aug.
6
Medication adherence and health empowerment in gout: a cross-sectional survey of patients.
Rheumatol Int. 2025 Jul 24;45(8):176. doi: 10.1007/s00296-025-05915-2.
7
Effects of a digitally enabled cardiac rehabilitation intervention on risk factors, recurrent hospitalization and mortality.
Eur Heart J Digit Health. 2025 Apr 29;6(4):688-703. doi: 10.1093/ehjdh/ztaf043. eCollection 2025 Jul.
8
Effect of a digital health intervention on outpatients with heart failure: a randomized, controlled trial.
Eur Heart J Digit Health. 2025 Jun 10;6(4):749-762. doi: 10.1093/ehjdh/ztaf063. eCollection 2025 Jul.
9
Study design and rationale of the AZIMUTH trial: a smartphone, app-based, E-health-integrated model of care for heart failure patients.
Eur Heart J Digit Health. 2025 Apr 24;6(4):840-848. doi: 10.1093/ehjdh/ztaf040. eCollection 2025 Jul.

本文引用的文献

1
Hypertension management: results of a new national survey for the hypertension education foundation: Harris interactive.
J Clin Hypertens (Greenwich). 2007 May;9(5):316-23. doi: 10.1111/j.1524-6175.2007.07152.x.
2
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.
Hypertension. 2007 Jan;49(1):69-75. doi: 10.1161/01.HYP.0000252676.46043.18. Epub 2006 Dec 11.
3
Clinical practice. Resistant or difficult-to-control hypertension.
N Engl J Med. 2006 Jul 27;355(4):385-92. doi: 10.1056/NEJMcp041698.
4
Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications.
Curr Opin Cardiol. 2006 Jul;21(4):310-5. doi: 10.1097/01.hco.0000231400.10104.e2.
5
6
Global burden of hypertension: analysis of worldwide data.
Lancet. 2005;365(9455):217-23. doi: 10.1016/S0140-6736(05)17741-1.
7
The burden of adult hypertension in the United States 1999 to 2000: a rising tide.
Hypertension. 2004 Oct;44(4):398-404. doi: 10.1161/01.HYP.0000142248.54761.56. Epub 2004 Aug 23.
8
Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients.
Curr Opin Cardiol. 2004 Jul;19(4):357-62. doi: 10.1097/01.hco.0000126978.03828.9e.
9
Primary prevention of essential hypertension.
Med Clin North Am. 2004 Jan;88(1):223-38. doi: 10.1016/s0025-7125(03)00126-3.
10
Patient adherence with hypertension medication.
J Manag Care Pharm. 2004 Jan-Feb;10(1):90-1. doi: 10.18553/jmcp.2004.10.1.90.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验